Review
Published on 08 Oct 2024
Current landscape of cystic fibrosis gene therapy
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1476331
- 2,569 views
Type at least 3 characters
588 articles
Articles
Original Research
Published on 25 Sep 2024
Airspaces-derived exosomes contain disease-relevant protein signatures in a mouse model of cystic fibrosis (CF)-like mucoinflammatory lung disease
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1460692
- 869 views
Review
Published on 24 Sep 2024
The critical roles of caveolin-1 in lung diseases
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1417834
- 1,139 views
Review
Published on 23 Sep 2024
3D cell culture models in research: applications to lung cancer pharmacology
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1438067
- 1,942 views
Original Research
Published on 19 Sep 2024
The glucocorticoid dose-mortality nexus in pneumonia patients: unveiling the threshold effect
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1445979
- 449 views
Original Research
Published on 13 Sep 2024
Aspirin reduces the mortality risk of patients with community-acquired pneumonia: a retrospective propensity-matched analysis of the MIMIC-IV database
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1402386
- 1,563 views
Original Research
Published on 11 Sep 2024
Triiodothyronine acts on DAO to regulate pulmonary fibrosis progression by facilitating cell senescence through the p53/p21 signaling pathway
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1433186
- 885 views
Original Research
Published on 06 Sep 2024
Dopamine, norepinephrine, and vasopressin accelerate particle transport velocity in murine tracheal epithelium via substance-specific receptor pathways: dependency on intra- and extracellular Ca2+ sources
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1401983
- 684 views
Review
Published on 30 Aug 2024
Lung fibrosis in sarcoidosis. Is there a place for antifibrotics?
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1445923
- 2,075 views
Original Research
Published on 27 Aug 2024
Developing a predictive nomogram for mortality in patients with extrapulmonary acute respiratory distress syndrome: the prognostic value of serum soluble thrombomodulin, lung ultrasound score, and lactate
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1407825
- 631 views
Review
Published on 22 Aug 2024
Pharmacological profile of dicaffeoylquinic acids and their role in the treatment of respiratory diseases
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1371613
- 768 views
Review
Published on 20 Aug 2024
Role of mitochondria in inflammatory lung diseases
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1433961
- 1,703 views
- 2 citations
Correction
Published on 12 Aug 2024
Corrigendum: Extracellular HSP90α interacts with ER stress to promote fibroblasts activation through PI3K/AKT pathway in pulmonary fibrosis
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1296214
- 690 views
Original Research
Published on 09 Aug 2024
Safety, effectiveness, and usefulness of higher-dose tablets of generic pirfenidone in patients with IPF: a nationwide observational study in South Korea
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1451447
- 2,389 views
Original Research
Published on 08 Aug 2024
Long-term effects of mepolizumab in patients with severe eosinophilic asthma: a 6-year real-life experience
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1449220
- 1,624 views
Original Research
Published on 07 Aug 2024
CKD-497 inhibits NF-kB signaling and ameliorates inflammation and pulmonary fibrosis in ovalbumin-induced asthma and particulate matter-induced airway inflammatory diseases
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1428567
- 1,289 views